Guanglin Bian

495 total citations
11 papers, 253 citations indexed

About

Guanglin Bian is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Guanglin Bian has authored 11 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Hematology and 2 papers in Oncology. Recurrent topics in Guanglin Bian's work include Immune Cell Function and Interaction (8 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Immunotherapy and Immune Responses (4 papers). Guanglin Bian is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Immunotherapy and Immune Responses (4 papers). Guanglin Bian collaborates with scholars based in United States, China and United Kingdom. Guanglin Bian's co-authors include Nicholas D. Leigh, Xuefang Cao, Xilai Ding, Lyudmila G. Burdelya, Semra Aygun‐Sunar, Andrei V. Gudkov, Jingxin Qiu, Philip L. McCarthy, Hong Liu and Katarzyna Bulek and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Guanglin Bian

11 papers receiving 251 citations

Peers

Guanglin Bian
Bethany Fixsen United States
Qingyong Ji United States
N Tatsumi Japan
Thea Brabb United States
Eric E. Irons United States
Rémy Char France
Bethany Fixsen United States
Guanglin Bian
Citations per year, relative to Guanglin Bian Guanglin Bian (= 1×) peers Bethany Fixsen

Countries citing papers authored by Guanglin Bian

Since Specialization
Citations

This map shows the geographic impact of Guanglin Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanglin Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanglin Bian more than expected).

Fields of papers citing papers by Guanglin Bian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanglin Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanglin Bian. The network helps show where Guanglin Bian may publish in the future.

Co-authorship network of co-authors of Guanglin Bian

This figure shows the co-authorship network connecting the top 25 collaborators of Guanglin Bian. A scholar is included among the top collaborators of Guanglin Bian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guanglin Bian. Guanglin Bian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Touw, William van der, Kyeongah Kang, Yi Luan, et al.. (2018). Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor B. The Journal of Immunology. 201(6). 1727–1734. 15 indexed citations
2.
Wang, Chenhui, Bradley N. Martin, Katarzyna Bulek, et al.. (2017). IL-17 induced NOTCH1 activation in oligodendrocyte progenitor cells enhances proliferation and inflammatory gene expression. Nature Communications. 8(1). 15508–15508. 83 indexed citations
3.
Bian, Guanglin, Nicholas D. Leigh, Wei Du, et al.. (2016). Interferon-Gamma Receptor Signaling Plays an Important Role in Restraining Murine Ovarian Tumor Progression.. PubMed. 1(1). 15–21. 5 indexed citations
4.
Du, Wei, Nicholas D. Leigh, Guanglin Bian, et al.. (2016). Granzyme B Contributes to the Optimal Graft-Versus-Tumor Effect Mediated by Conventional CD4+ T Cells.. PubMed. 1(1). 22–28. 11 indexed citations
5.
Du, Wei, Nicholas D. Leigh, Guanglin Bian, et al.. (2015). Granzyme B–Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease. The Journal of Immunology. 195(9). 4514–4523. 16 indexed citations
6.
Leigh, Nicholas D., Guanglin Bian, Xilai Ding, et al.. (2014). A Flagellin-Derived Toll-Like Receptor 5 Agonist Stimulates Cytotoxic Lymphocyte-Mediated Tumor Immunity. PLoS ONE. 9(1). e85587–e85587. 51 indexed citations
7.
Leigh, Nicholas D., Guanglin Bian, Xilai Ding, et al.. (2013). Acute TLR5 stimulation with a flagellin-derived agonist induces cytotoxic lymphocyte-mediated tumor immunity (P2064). The Journal of Immunology. 190(Supplement_1). 132.22–132.22. 1 indexed citations
9.
Bian, Guanglin, Xilai Ding, Nicholas D. Leigh, et al.. (2012). Granzyme B–Mediated Damage of CD8+ T Cells Impairs Graft-versus-Tumor Effect. The Journal of Immunology. 190(3). 1341–1350. 20 indexed citations
10.
Ding, Xilai, Guanglin Bian, Nicholas D. Leigh, et al.. (2012). A TLR5 Agonist Enhances CD8+ T Cell-Mediated Graft-versus-Tumor Effect without Exacerbating Graft-versus-Host Disease. The Journal of Immunology. 189(10). 4719–4727. 24 indexed citations
11.
Bian, Guanglin, Yu‐Ming Cheng, Zekun Wang, et al.. (2009). Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses. Vaccine. 28(1). 187–194. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026